BE695974A - - Google Patents
Info
- Publication number
- BE695974A BE695974A BE695974DA BE695974A BE 695974 A BE695974 A BE 695974A BE 695974D A BE695974D A BE 695974DA BE 695974 A BE695974 A BE 695974A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- days
- malaria
- dead
- sulfametine
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 239000003430 antimalarial agent Substances 0.000 claims description 20
- 230000000078 anti-malarial effect Effects 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 15
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 2
- RONWGALEIBILOG-VMJVVOMYSA-N quinine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 RONWGALEIBILOG-VMJVVOMYSA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 description 46
- 239000003814 drug Substances 0.000 description 46
- 241000699670 Mus sp. Species 0.000 description 29
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 26
- 229960003677 chloroquine Drugs 0.000 description 26
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 26
- 238000011081 inoculation Methods 0.000 description 20
- 208000015181 infectious disease Diseases 0.000 description 18
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 15
- 241000224016 Plasmodium Species 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 10
- 229960000611 pyrimethamine Drugs 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- GPTONYMQFTZPKC-UHFFFAOYSA-N sulfamethoxydiazine Chemical compound N1=CC(OC)=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1 GPTONYMQFTZPKC-UHFFFAOYSA-N 0.000 description 9
- 238000011282 treatment Methods 0.000 description 8
- 229960002229 sulfametoxydiazine Drugs 0.000 description 7
- 241000283984 Rodentia Species 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 241000124008 Mammalia Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- -1 methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isoamoxy Chemical group 0.000 description 5
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 4
- 241000224017 Plasmodium berghei Species 0.000 description 4
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 4
- 239000001177 diphosphate Substances 0.000 description 4
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 4
- 235000011180 diphosphates Nutrition 0.000 description 4
- 229940126701 oral medication Drugs 0.000 description 4
- 238000011321 prophylaxis Methods 0.000 description 4
- 241000223829 Plasmodium vinckei Species 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- ZGJHFPBCIVRXAQ-UHFFFAOYSA-N 7-(hydroxymethyl)-2,3-dihydropyrrolizin-1-one Chemical compound C1CC(=O)C2=C(CO)C=CN21 ZGJHFPBCIVRXAQ-UHFFFAOYSA-N 0.000 description 2
- OVCDSSHSILBFBN-UHFFFAOYSA-N Amodiaquine Chemical compound C1=C(O)C(CN(CC)CC)=CC(NC=2C3=CC=C(Cl)C=C3N=CC=2)=C1 OVCDSSHSILBFBN-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229960001444 amodiaquine Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229960004171 hydroxychloroquine Drugs 0.000 description 2
- XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 229960000948 quinine Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical compound C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 1
- 150000000191 1,4-naphthoquinones Chemical class 0.000 description 1
- CXIUWTTYUPDMGW-UHFFFAOYSA-N 4,4-dimethyl-1h-1,3,5-triazine Chemical compound CC1(C)NC=NC=N1 CXIUWTTYUPDMGW-UHFFFAOYSA-N 0.000 description 1
- GJOHLWZHWQUKAU-UHFFFAOYSA-N 5-azaniumylpentan-2-yl-(6-methoxyquinolin-8-yl)azanium;dihydrogen phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 GJOHLWZHWQUKAU-UHFFFAOYSA-N 0.000 description 1
- 150000005012 8-aminoquinolines Chemical class 0.000 description 1
- 150000005027 9-aminoacridines Chemical class 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000427199 Bosea <angiosperm> Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 101100314584 Rattus norvegicus Trim3 gene Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940058936 antimalarials diaminopyrimidines Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- QTPSDCFAVWZIJU-UHFFFAOYSA-N chembl3092109 Chemical compound O=C1C2=CC=CC=C2C(=O)C(O)=C1CCCC1CCCCC1 QTPSDCFAVWZIJU-UHFFFAOYSA-N 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 229960000901 mepacrine Drugs 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960005179 primaquine Drugs 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- MISVBCMQSJUHMH-UHFFFAOYSA-N pyrimidine-4,6-diamine Chemical class NC1=CC(N)=NC=N1 MISVBCMQSJUHMH-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53663066A | 1966-03-23 | 1966-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE695974A true BE695974A (enrdf_load_stackoverflow) | 1967-09-25 |
Family
ID=24139285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE695974D BE695974A (enrdf_load_stackoverflow) | 1966-03-23 | 1967-03-23 |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE695974A (enrdf_load_stackoverflow) |
| FR (1) | FR6659M (enrdf_load_stackoverflow) |
| NL (1) | NL6704268A (enrdf_load_stackoverflow) |
-
1967
- 1967-03-22 NL NL6704268A patent/NL6704268A/xx unknown
- 1967-03-23 FR FR99943A patent/FR6659M/fr not_active Expired
- 1967-03-23 BE BE695974D patent/BE695974A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR6659M (enrdf_load_stackoverflow) | 1969-01-27 |
| NL6704268A (enrdf_load_stackoverflow) | 1967-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6636108B2 (ja) | アスタキサンチン抗炎症性相乗的組み合わせ | |
| Mishra et al. | Alkaloids: future prospective to combat leishmaniasis | |
| Kevin Ii et al. | Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites | |
| DE60202278T2 (de) | Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten | |
| IE72095B1 (en) | Antimalarial compositions | |
| JP6803898B2 (ja) | オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ | |
| Ramanitrahasimbola et al. | Biological activities of the plant‐derived bisindole voacamine with reference to malaria | |
| JP2019515909A (ja) | 慢性リンパ性白血病の治療を目的とするｈｄａｃ阻害剤単独またはｂｔｋ阻害剤との配合物 | |
| US20140308378A1 (en) | Bidens pilosa and polyacetylenic compounds for prevention and treatment of coccidiosis | |
| SK94297A3 (en) | New applications of lysozyme dimer | |
| FR2639830A1 (fr) | Composition antivirale et ses applications | |
| EP0214933A2 (de) | Kombinationspräparate zur Behandlung von Malaria | |
| BE695974A (enrdf_load_stackoverflow) | ||
| KR102023380B1 (ko) | 봉독을 유효성분으로 포함하는 콕시듐증의 예방 또는 치료용 조성물 | |
| US3761594A (en) | Composition for control of coccidiosis containing a coccidiostiatically active 4-hydroxy-quinoline and meticlorpindol | |
| FR2722987A1 (fr) | Utilisation de l'eliprodil et de ses enantiomeres pour la preparation de medicaments utiles dans la prevention des neuropathiesinduites par des agentsanticancereux | |
| EP0139551A2 (fr) | Medicament immunomodulateur d'origine biologique et son procédé de préparation | |
| KR101507651B1 (ko) | 소리쟁이 추출물을 포함하는 말라리아 치료용 약학적 조성물 | |
| JP6967247B1 (ja) | 抗マラリア剤 | |
| WO2015001799A1 (ja) | バベシア症の治療剤及び予防剤 | |
| JP2020503315A (ja) | 肝損傷を予防または治療する医薬組成物の調製における（２ｒ，４ｒ）−１，２，４−トリヒドロキシヘプタデカ−１６−インの応用 | |
| Widyawaruyanti et al. | Various Parts of Helianthus annuus Plants as New Sources of Antimalarial Drugs | |
| Widyawaruyanti et al. | Research Article Various Parts of Helianthus annuus Plants as New Sources of Antimalarial Drugs | |
| Chaudhuri et al. | Dichroa febrifuga and a synthetic hydrangea alkaloid in malaria | |
| US6214357B1 (en) | Treatment of diabetes |